A phase I trial of temsirolimus and pemetrexed in patients with advanced non-small cell lung cancer

le Waqar, Saiama N., Baggstrom, Maria Q., Morgensztern, Daniel, Williams, Kristina, Rigden, Caron, Govindan, Ramaswamy
Foilsithe in Chemotherapy (2016)

Delayed nausea and vomiting from carboplatin doublet chemotherapy

le Waqar, Saiama N., Mann, Janelle, Baggstrom, Maria Q., Waqar, Muhammad Atif, Chitneni, Pooja, Williams, Kristina, Gao, Feng, Morgensztern, Daniel, Govindan, Ramaswamy
Foilsithe in Acta Oncol (2016)

A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive stage small cell lung cancer (ES-SCLC)

le Baggstrom, Maria Q., Qi, Yingwei, Koczywas, Marianna, Argiris, Athanassios, Johnson, Elizabeth A., Millward, Michael J., Murphy, Sara C., Erlichman, Charles, Rudin, Charles M., Govindan, Ramaswamy
Foilsithe 2011

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST refere...

le Arnold, Susanne M., Chansky, Kari, Leggas, Markos, Thompson, Michael A., Villano, John L., Hamm, John, Sanborn, Rachel E., Weiss, Glen J., Chatta, Gurkamal, Baggstrom, Maria Q.
Foilsithe in Invest New Drugs (2017)

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

le Gerber, David E., Swanson, Paul, Lopez-Chavez, Ariel, Wong, Lucas, Dowlati, Afshin, Pennell, Nathan A., Cronier, Damien M., Qin, Amy, Ilaria, Robert, Cosaert, Jan, Shahir, Ashwin, Baggstrom, Maria Q.
Foilsithe in Lung Cancer (2017)

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled...

le Baggstrom, Maria Q., Socinski, Mark A., Wang, Xiaofei F., Gu, Lin, Stinchcombe, Thomas E., Edelman, Martin J., Baker, Sherman, Feliciano, Josephine, Novotny, Paul, Hahn, Olwen, Crawford, Jeffrey A., Vokes, Everett E.
Foilsithe in J Thorac Oncol (2017)

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non–Small Cell Lung Cancer: A Phase 2 Randomized Clinical...

le Stinchcombe, Thomas E., Jänne, Pasi A., Wang, Xiaofei, Bertino, Erin M., Weiss, Jared, Bazhenova, Lyudmila, Gu, Lin, Lau, Christie, Paweletz, Cloud, Jaslowski, Anthony, Gerstner, Gregory J., Baggstrom, Maria Q., Graziano, Stephen, Bearden, James, Vokes, Everett E.
Foilsithe in JAMA Oncol (2019)

Postoperative Radiotherapy for Pathologic N2 Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base

le Robinson, Cliff G., Patel, Aalok P., Bradley, Jeffrey D., DeWees, Todd, Waqar, Saiama N., Morgensztern, Daniel, Baggstrom, Maria Q., Govindan, Ramaswamy, Bell, Jennifer M., Guthrie, Tracey J., Colditz, Graham A., Crabtree, Traves D., Kreisel, Daniel, Krupnick, Alexander S., Patterson, G. Alexander, Meyers, Bryan F., Puri, Varun
Foilsithe in J Clin Oncol (2015)

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexp...

le Edelman, Martin J., Wang, Xiaofei, Hodgson, Lydia, Cheney, Richard T., Baggstrom, Maria Q., Thomas, Sachdev P., Gajra, Ajeet, Bertino, Erin, Reckamp, Karen L., Molina, Julian, Schiller, Joan H., Mitchell-Richards, Kisha, Friedman, Paula N., Ritter, Jon, Milne, Ginger, Hahn, Olwen M., Stinchcombe, Thomas E., Vokes, Everett E.
Foilsithe in J Clin Oncol (2017)